MEK1/2 inhibition decreases pro-inflammatory responses in macrophages from people with cystic fibrosis and mitigates severity of illness in experimental murine methicillin-resistant Staphylococcus aureus infection https://www.biorxiv.org/content/10.1101/2023.01.22.525092v1?med=mas